Anturec Pharmaceuticals
Germany - FrankfurtPharmaceutical
Focus: Anturec Pharmaceuticals is a German-based public company founded in 2020 focused on cancer therapies with expansion into neurology. The company operates as a publicly-listed oncology specialist with limited disclosed market scale.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Anturec Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Anturec Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Trabectedin
Soft Tissue SarcomaClinical Trials (1)
NCT05597917tTF-NGR Randomized Study - STS
Phase 3Help build intelligence for Anturec Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.